Press Release: DELFI : DELFI Diagnostics Working with Incendia Therapeutics to Employ Advanced Treatment Monitoring Test in a Phase 1 Clinical Trial
/PRNewswire/ -- DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, today announced that...
Read full article »
Delfi is a Maryland-based biotechnology company that research and develops fluid biopsy tests for the early detection of cancer.
Read more